Progress on JAXPORT’s vehicle berth
Jun 2, 2026 at 7:15 AM
ELVIS warns of economic risks
Jun 2, 2026 at 7:27 AM
The Israeli shipping company ZIM Integrated Shipping Services Ltd. has appointed Dr. Chen Lichtenstein as the new President and CEO of the company. This decision follows the resignation of Eli Glickman on April 15, 2026. Dr. Lichtenstein will assume his new position on July 1, 2026, and will also become a member of the board. The employment contract between ZIM and Dr. Lichtenstein must be approved by the shareholders in accordance with the Israeli Companies Law of 1999.
Experience and qualifications
Dr. Lichtenstein brings extensive experience in corporate management, finance, and international business. He has previously led complex international companies and was responsible for growth processes as well as organizational changes. From 2020 to 2023, he served as Chief Financial Officer of Syngenta Group, a global agritech company. In this role, he was significantly involved in the strategic development and integration of the company and contributed to efficiency improvements and the management of a complex debt structure.
Prior to that, Dr. Lichtenstein was President and CEO of ADAMA Ltd. from 2014 to 2020, where he led the company during a period of significant growth and improved profitability. His career also includes positions at China National Agrochemical Corporation and various leadership roles within Makhteshim Agan Industries. Additionally, he worked as a senior investment banker at Goldman Sachs in New York and London from 1999 to 2006.
Currently, Dr. Lichtenstein is a board member of Teva Pharmaceuticals Ltd. and chairman of several international companies in the fields of environmental sciences and biotechnology. He holds a Ph.D. from Stanford University as well as degrees in physics and law from the Hebrew University of Jerusalem.
Outlook and goals
Dr. Lichtenstein’s appointment followed a search process that also involved Chairman Yair Seroussi and board members Dr. Yoram Turbowicz and Yair Avidan. Seroussi spoke positively about Dr. Lichtenstein’s qualifications and emphasized his ability to lead complex global organizations.
Dr. Lichtenstein himself stated that he appreciates the opportunity to lead a global Israeli company with a significant history and international success. He emphasized the importance of the company’s stability as well as enhancing performance and creating value for customers, employees, partners, and shareholders.
